MARKET

BDRX

BDRX

Biodexa Pharmaceuticals plc
NASDAQ
1.160
-0.170
-12.78%
Opening 10:16 09/16 EDT
OPEN
1.230
PREV CLOSE
1.330
HIGH
1.270
LOW
1.145
VOLUME
1.34M
TURNOVER
--
52 WEEK HIGH
59.40
52 WEEK LOW
0.6100
MARKET CAP
1.19M
P/E (TTM)
-29.5918
1D
5D
1M
3M
1Y
5Y
1D
Biodexa Pharmaceuticals Secures $2.3 Million Via Warrant Exercise Deal
TipRanks · 1d ago
Biodexa Pharmaceuticals enters warrant exercise transaction for $2.3M gross proceeds; shares rise
Seeking Alpha · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 1d ago
Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 2d ago
Weekly Report: what happened at BDRX last week (0907-0911)?
Weekly Report · 2d ago
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Biodexa Pharmaceuticals Posts Interim 1H26 Results and Expands GI Cancer Pipeline
TipRanks · 4d ago
More
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Webull offers Biodexa Pharmaceuticals PLC-ADR stock information, including NASDAQ: BDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDRX stock methods without spending real money on the virtual paper trading platform.